Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Achyut Healthcare Ltd met on October 16, 2025 and approved the unaudited financial results for the half year ended September 30, 2025, along with the Limited Review Report from statutory auditors Doshi Doshi & Co. Revenue from operations rose sharply to about Rs. 563.87 lakhs in H1 FY26 from Rs. 212.66 lakhs in H1 FY25, more than doubling year-on-year. Net profit for the period came in at roughly Rs. 23 lakhs versus Rs. 12 lakhs in the previous year, also nearly doubling. Total expenses grew significantly to about Rs. 552 lakhs (from Rs. 105 lakhs), indicating a much higher cost base. The company continues to operate in a single segment — pharmaceutical trading — and is listed on the SME exchange, so it is exempt from mandatory IndAS adoption.
Higher revenue and improved profits are positive signals for shareholders, showing operational scale-up, though the sharp jump in expenses warrants a closer look at margins. The clean limited review report (unqualified) supports confidence in the numbers; no major corporate action like dividend or fundraising was announced in this meeting.